Іздеу

Шығарылым
Атауы
Авторлар
The structure of the prevalence of cardiovascular diseases and chronic kidney disease in patients with type 2 diabetes mellitus in the stationary care
Demidova T., Izmailova M.
New possibilities of uratedecreasing therapy in patients with arthrolithiasis
Petrova M., Musiichuk M., Inamova O., Mazurov V.
Inflammatory bowel diseases and cardiovascular pathology: pathogenetic correlations and age-related peculiarities
Khlynova O., Stepina E., Trapeznikova A.
Prognostic value of cardiac troponins in case of COVID-19
Alieva A., Reznik E., Teplova N., Batov M., Shnahova L., Arakelyan R., Baykova I., Totolyan G., Volynkina V., Kislyakov V., Nikitin I.
Effect of platelets on the course of rheumatoid arthritis and cardiovascular risk
Mazurov V., Melnikov E., Bashkinov R.
Gut microbiome modulation and cardiovascular risks: mechanisms of formation and correction
Livzan M., Bikbavova G., Safiulina T., Loginova E.
JDP2 - a new promising biological marker in cardiovascular pathology
Alieva A., Reznik E., Teplova N., Totolyan G., Gasanova E., Kalova M., Sabanchieva E., Nikitin I.
Resistin and cardiovascular pathology
Alieva A., Baykova I., Khadzhieva N., Ettinger O., Arakelyan R., Valiev R., Rakhaev A., Batov M., Elmurzaeva D., Malkarova D., Nikitin I.
About fundamental and clinical aspects of magnesium and ribolavine synergic action in therapeutic practice
Gromova O., Torshin I., Kobalava Z., Sorokina M.
The importance of a multifactorial approach in the treatment of type 2 diabetes mellitus: clinical cases
Podorozhnyuk K., Skuridina D.
Advantages of combined use of sodium-glucose co-transporter type 2 inhibitors and glucagon-like peptide-1 receptor agonists relatively to cardiovascular and renal outcomes in patients with type 2 diabetes mellitus
Salukhov V., Shustov S., Petrankov K.
Calculation of cardiovascular risk in patients with premature ovarian insufficiency depending on its etiology
Lopukhov S., Nikiforov A., Filippov E.
INTERLEUKIN 37 IS A NEW BIOLOGICAL MARKER FOR CARDIOVACULAR PATHOLOGY
Alieva A., Reznik E., Teplova N., Arakelyan R., Shnakhova L., Baykova I., Akkieva M., Nikitin I.
Issues of pathogenesis of cognitive and psychoemotional disorders in patients with cardiovascular and metabolic diseases
Shishkova V., Kotova M., Kapustina L., Imamgayazova K.
Prevalence of some managed risk factors of cardiovascular diseases among young students
Kardangusheva A., Shugusheva Z., Bekulova I., Bekaidieva N., TEUNOVA M.
PECULIARITIES OF CARDIOVASCULAR OUTCOMES IN MALE AND FEMALE PATIENTS AFTER NOVEL CORONAVIRUS INFECTION CAUSED BY SARS-CoV-2
Glibko K., Arakelov S., Titova I., Kasaeva D., Larina V.
Left-sided infectious endocarditis in a patient receiving program hemodialysis treatment
Ponomareva E., Sedov D.
Type 2 diabetes mellitus and cardiovascular diseases. Therapy that changes prognosis
Demidova T., Pugovkina Y.
Febuxostat: efficacy and safety of the drug, prospects for application (literature review)
Shchemeleva E., Skorodumova E.
Patients with cardiovascular diseases and NSAIDs intake: is there a real problem today?
Rebrov A., Tyapkina M., Ordyakova A., Yupatov V., Kosheleva N., Basov I.
Assessment of the risk of developing cardiovascular diseases on the SCORE-2 and SCORE 2-OP scale in patients with arterial hypertension using software tools
Derevyanchenko M., Fedotov V., Shaposhnikova M., Kolodin S.
Features of course of arterial hypertension in patients with type 2 diabetes mellitus, its role in the development of vascular complications
Yermakova Y., Kochergina I.
Epidemiology of atherosclerotic cardiovascular diseases in some regions of the Russian Federation, clinical characteristics of patients and estimation of the efficacy of lipid-lowing therapy: study of real clinical practice
Tuaeva I., Astakhova Z.
Hyperuricemia and reduced glomerular filtration rate in the population among Nizhny Novgorod region inhabitants
Borovkova N., Kurashin V., Tokareva A., Makarova E., Nekrasov A., Savitskaya N., Mironov M.
Biomarkers in cardiology: lipocalin associated with neutrophil gelatinase (NGAL) and cardiovascular diseases
Alieva A., Teplova N., Reznik E., Valiev R., Rakhaev A., Kudaeva M., Akhmatov I., Arakelyan R., Nikitin I.
COVID-19 and cardiovascular diseases: a dangerous tandem
Avdeeva I., Burko N., Makarova K., Makarova K., Oleynikov V.
CARDIOVASCULAR DISEASES AT THE PREHOSPITAL STAGE: HOW TO IMPROVE THE EFFECTIVENESS OF CARE?
Mychka V., Uzueva E.
Diagnostic and therapeutic aspects of irisin in cardiovascular pathology and metabolic disorders
Alieva A., Nikitin I., Teplova N., Baykova I., Rakhaev A., Kudaeva M., Sozaeva M., Kotikova I.
Practical issues of oral iron administration for anemia in patients with cardiovascular diseases
Posnenkova O., Kaluta T.
The relationship of environmental risk factors and cardiovascular diseases in hypertensive patients living in rural areas
Yesina E., Zuikova A., Kotova Y.
Impact of hyperuricemia at the clinical course of systemic lupus erythematosus and comorbid conditions in young and middle-aged female patients
Musiychuk M., Gaydukova I., Mazurov V., Inamova O., Aliev D., Lapin S.
The role of interleukin 12 in the development of cardiovascular diseases
Alieva A., Teplova N., Ettinger O., Reznik E., Baykova I., Sarakaeva L., Shnahova L., Arakelyan R., Valiev R., Nikitin I.
Possibility ofhigh-selective adrenoblockers use in combined therapy of patients with metabolic syndrome
Tolpygina S.
Structural and functional condition of the vascular wall in multiple sclerosis patients
Semenyukova O., Adasheva T., Boyko A., Timofeeva N.
Modern viewpoint at prediabetes: Prevalence, diagnostic criteria, risk groups, screening
Larina V., Lankin A., Larin V., Golovko M.
Review of current opportunities in cardiovascular risks management in patients with type 2 diabetes mellitus
Demidova T., Mkrtamyan A.
Estimation of hypolipidemic psillium effect in gastroenterologic patients with lipid metabolism disorders
Levchenko S., Komissarenko I.
Arterial hypertension and longevity
Reznik E., Golubev Y., Zhuravlev A., Yurtaeva N., Ischenko G.
Нәтижелер 38 - 1/38
Сыбырсөздер:
  • Негізгі сөздер тіркелімге сезімтал< / li>
  • Ағылшын предлогтары мен одақтары еленбейді
  • Әдепкі бойынша іздеу барлық негізгі сөздер үшін жасалады (агенс AND экспериенцер)
  • Белгілі бір терминді табу үшін OR қолданыңыз. білім беру OR оқыту
  • мысалы, күрделі сөз тіркестерін жасау үшін жақшаларды қолданыңыз. мұрағат ((журналдар OR конференциялар) NOT диссертациялар)
  • Нақты фразаны табу үшін, мысалы, тырнақшаларды қолданыңыз. "ғылыми зерттеулер"
  • сөзді - (сызықша) немесе not операторының көмегімен алып тастаңыз; мысалы. сұлулық байқауы< / em > немесе сұлулық байқауы< / em > < / li>
  • мысалы, нұсқа ретінде * қолданыңыз. ғылым* "ғылыми","ғылыми"және т. б. сөздерді қамтиды< / li> < / < / к-сі>